fibrinogen has been researched along with Antiphospholipid Syndrome in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (21.74) | 18.2507 |
| 2000's | 9 (39.13) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Boissier, E; Douxfils, J; Gaudard, M; Lebreton, A; Sapin, AF; Sinegre, T; Talon, L | 1 |
| Goya, T; Kato, M; Kohjima, M; Mutsuki, T; Ohe, M; Satoh, T; Yamashita, S | 1 |
| Belaj, K; Brodmann, M; Bruckenberger, R; Froehlich, H; Gary, T; Hackl, G; Hafner, F; Pilger, E; Zebisch, A | 1 |
| Fuenmayor, J; Garmendia, J; Kanzler, D; Marchi, R | 1 |
| Furie, B; Furie, BC; Furie, RA; Merrill-Skoloff, G; Proulle, V | 1 |
| Habe, K; Ikeda, T; Ikejiri, M; Kamimoto, Y; Matsumoto, T; Mizutani, H; Murabayashi, N; Nakatani, K; Ohishi, K; Osato, K; Sugiyama, T; Wada, H | 1 |
| Ames, PR; Brancaccio, V; Chis Ster, I; D'Andrea, G; Iannaccone, L; Margaglione, M; Marottoli, V; Merashli, M | 1 |
| Dai, J; Ding, Q; Hu, Y; Liang, Q; Lu, Y; Ouyang, Q; Wang, H; Wang, X; Wu, W; Wu, X; Xie, Y; Zhou, J | 1 |
| Albright, RC; Bridges, AD; Claus, PL; Davis, MD; Dillon, JJ; El-Azhary, RA; El-Zoghby, ZM; Hickson, LJ; Kumar, R; McBane, RD; McCarthy, JT; McCarthy-Fruin, KA; McEvoy, MT; Patzelt, MT; Pittelkow, MR; Weaver, AL; Wetter, DA; Williams, AW | 1 |
| Bové, A; Cervera, R; de la Red, G; Espinosa, G; Monteagudo, J; Plaza, J; Reverter, JC; Tàssies, D | 1 |
| Arnout, J; de Groot, PG; Derksen, RH; Lenting, PJ; Lutters, BC; Tekelenburg, WL | 1 |
| Amigo, MC; Cortina, E; de la Peña, A; de Pablo, P; Izaguirre, R; Ramírez, A; Zamora, J | 1 |
| Bossi, F; Bulla, R; Debeus, A; Durigutto, P; Fischetti, F; Macor, P; Meroni, P; Pellis, V; Sblattero, D; Tedesco, F; Ziller, F | 1 |
| Kelemen, A; Kolev, K; Léránt, I; Machovich, R; Nagy, Z; Skopál, J | 1 |
| Kveder, T; Peternel, P; Poredos, P; Sebestjen, M; Stalc, M; Tomsic, M | 1 |
| Beyan, C; Beyan, E; Turan, M | 1 |
| Ames, PR; Brancaccio, V; Iannaccone, L; Pyke, S | 1 |
| Bakowska, A; Borowska-Lehman, J; Chrostowski, L; Izycka, E; Michowska, M; Rzepko, R | 1 |
| Watanabe, K | 1 |
| Akiguchi, I; Kimura, J; Kinoshita, M; Nishimura, M; Osaki, A; Tomimoto, H; Wakita, H | 1 |
| Barlage, S; Lackner, KJ; Schmitz, G; von Landenberg, C | 1 |
| Mannucci, PM; Tripodi, A | 1 |
| Cattaneo, M; de Franchis, R; Mannucci, PM; Vecchi, M | 1 |
2 review(s) available for fibrinogen and Antiphospholipid Syndrome
| Article | Year |
|---|---|
[Clinical diagnosis of thrombosis and blood coagulation tests].
Topics: Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Antithrombin III; Biomarkers; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrinogen; Humans; Lupus Coagulation Inhibitor; Protein C; Protein S; Reference Standards; Thrombophilia | 1998 |
Laboratory investigation of thrombophilia.
Topics: Activated Protein C Resistance; Antiphospholipid Syndrome; Antithrombins; Clinical Laboratory Techniques; Coronary Thrombosis; Factor V; Factor VIII; Fibrinogen; Humans; Hyperhomocysteinemia; Mutation; Protein C; Protein S; Prothrombin; Stroke; Thrombophilia; Venous Thrombosis | 2001 |
21 other study(ies) available for fibrinogen and Antiphospholipid Syndrome
| Article | Year |
|---|---|
Stability of coagulation parameters in plasma samples at room temperature after one freeze/thaw cycle.
Topics: Anticoagulants; Antiphospholipid Syndrome; Blood Coagulation Tests; Fibrinogen; Freezing; Heparin; Heparin, Low-Molecular-Weight; Humans; Lupus Coagulation Inhibitor; Partial Thromboplastin Time; Rivaroxaban; Temperature | 2022 |
Portal Vein Thrombosis Repeatedly Observed in a Cirrhotic Patient with Antiphospholipid Antibody Syndrome.
Topics: Antiphospholipid Syndrome; Fibrin; Fibrinogen; Humans; Liver Cirrhosis; Male; Middle Aged; Portal Vein; Tomography, X-Ray Computed; Venous Thrombosis | 2016 |
Primary antiphospholipid antibody syndrome-one further aspect of thrombophilia in overweight and obese patients with venous thromboembolism.
Topics: Adult; Aged; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Body Mass Index; Body Weight; Female; Fibrinogen; Humans; Inflammation; Male; Middle Aged; Obesity; Overweight; Retrospective Studies; Risk Factors; Thrombophilia; Venous Thromboembolism | 2013 |
Study of the fibrinolytic process in a patient with antiphospholipid syndrome.
Topics: Abortion, Habitual; Adult; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Autoantibodies; Autoantigens; beta 2-Glycoprotein I; Blood Coagulation; Dose-Response Relationship, Drug; Female; Fibrinogen; Fibrinolysis; Humans; Immunoglobulin G; Lupus Coagulation Inhibitor; Nephelometry and Turbidimetry; Polymerization; Pre-Eclampsia; Pregnancy; Prothrombin; Thrombin; Thrombophlebitis; Tissue Plasminogen Activator | 2015 |
Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS.
Topics: Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Autoantibodies; beta 2-Glycoprotein I; Blood Platelets; Blotting, Western; Cell Membrane; Cells, Cultured; Disease Models, Animal; Endothelium; Fibrin; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Mice; Mice, Inbred C57BL; Platelet Activation; Thrombosis | 2014 |
Hypofibrinogenemia and the α-Fibrinogen Thr312Ala Polymorphism may be Risk Factors for Early Pregnancy Loss.
Topics: Abortion, Habitual; Adult; Afibrinogenemia; Antiphospholipid Syndrome; Cohort Studies; Female; Fibrinogen; Humans; Polymorphism, Genetic; Pregnancy; Protein C Deficiency; Risk Factors | 2017 |
Survival in primary antiphospholipid syndrome. A single-centre cohort study.
Topics: Adult; Aged; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Aryldialkylphosphatase; Blood Coagulation Tests; Cohort Studies; Female; Fibrinogen; Follow-Up Studies; Humans; Italy; Lupus Coagulation Inhibitor; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Partial Thromboplastin Time; Proportional Hazards Models; Prothrombin; Risk Factors; von Willebrand Factor | 2016 |
Dysfibrinogenemia-associated novel heterozygous mutation, Shanghai (FGA c.169_180+2 del), leads to N-terminal truncation of fibrinogen Aα chain and impairs fibrin polymerization.
Topics: Afibrinogenemia; Antiphospholipid Syndrome; China; Fibrin; Fibrinogen; Humans; Male; Mutation; Venous Thrombosis; Young Adult | 2017 |
Calciphylaxis: A Disease of Pannicular Thrombosis.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antiphospholipid Syndrome; Calciphylaxis; Factor V; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Male; Middle Aged; Mutation; Plasminogen; Thrombophilia; Warfarin | 2016 |
Factor XIII-A subunit Val34Leu polymorphism is associated with the risk of thrombosis in patients with antiphospholipid antibodies and high fibrinogen levels.
Topics: Adult; Antiphospholipid Syndrome; Case-Control Studies; Factor XIII; Female; Fibrinogen; Gene Frequency; Genetic Predisposition to Disease; Humans; Leucine; Male; Odds Ratio; Polymorphism, Genetic; Protein Subunits; Risk Assessment; Risk Factors; Thrombosis; Up-Regulation; Valine | 2009 |
Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'.
Topics: Antibodies, Monoclonal; Antiphospholipid Syndrome; beta 2-Glycoprotein I; Blood Platelets; Cell Adhesion; Collagen; Dimerization; Female; Fibrinogen; Fibronectins; Glycoproteins; Humans; LDL-Receptor Related Proteins; Ligands; Microscopy, Fluorescence; Perfusion; Phospholipids; Platelet Aggregation; Precipitin Tests; Protein Binding; Receptors, LDL; Receptors, Lipoprotein; Signal Transduction; Thromboxanes; Transfection | 2003 |
Increased fibrin polymerization rate in patients with primary antiphospholipid syndrome and systemic lupus erythematosus.
Topics: Adult; Antiphospholipid Syndrome; Blood Coagulation; Female; Fibrin; Fibrinogen; Humans; Kinetics; Lupus Erythematosus, Systemic; Male; Reference Values | 2003 |
Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor.
Topics: Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Autoantibodies; beta 2-Glycoprotein I; Blood Coagulation; Complement C3; Complement C5; Complement C9; Complement System Proteins; Endothelium, Vascular; Escherichia coli; Female; Fibrinogen; Glycoproteins; Humans; Immunoglobulin G; Inflammation; Lipopolysaccharides; Male; Microscopy, Fluorescence; Protein Structure, Tertiary; Rats; Rats, Wistar; Thrombosis; Time Factors; Venous Thrombosis | 2005 |
Impaired inactivation by antithrombin and hirudin and preserved fibrinogen-clotting activity of thrombin in complex with anti-thrombin antibody from a patient with antiphospholipid syndrome.
Topics: Adult; Antigens; Antiphospholipid Syndrome; Antithrombins; Blood Coagulation; Blood Coagulation Tests; Blotting, Western; Factor XIII; Female; Fibrinogen; Hirudins; Humans; Immunoglobulin G; Lupus Erythematosus, Systemic; Protein C; Thrombin; Time Factors | 2005 |
Endothelial function is impaired in patients with primary antiphospholipid syndrome.
Topics: Administration, Oral; Adult; Aged; Anticoagulants; Antiphospholipid Syndrome; Brachial Artery; Endothelium, Vascular; Female; Fibrinogen; Humans; Intercellular Adhesion Molecule-1; Male; Middle Aged; Nitroglycerin; Reproducibility of Results; Risk Factors; Vascular Cell Adhesion Molecule-1; Vasodilation | 2006 |
Hematological presentation in systemic lupus erythematosus and its relationship with disease activity.
Topics: Adolescent; Adult; Anemia; Antiphospholipid Syndrome; Complement C3; Complement C4; Female; Fibrinogen; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Pancytopenia; Thrombocytopenia | 2007 |
Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
Topics: Adolescent; Adult; Aged; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Autoimmune Diseases; Blood Coagulation Tests; Disease Susceptibility; Female; Fibrinogen; Hemostasis; Humans; Immunoglobulin G; Lupus Erythematosus, Systemic; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Thromboembolism; Thrombophlebitis; von Willebrand Factor | 1995 |
Antiphospholipid syndrome in systemic lupus erythematosus--immunomorphological study of the central nervous system; case report.
Topics: Adult; Antiphospholipid Syndrome; Brain; Complement C3; Fatal Outcome; Female; Fibrinogen; Humans; Immunoglobulin G; Immunohistochemistry; Lupus Erythematosus, Systemic; Spinal Cord | 1995 |
Effects of antithrombin on Binswanger's disease with antiphospholipid antibody syndrome.
Topics: Antiphospholipid Syndrome; Antithrombin III; Antithrombins; Arginine; Basal Ganglia Diseases; Dementia, Multi-Infarct; Female; Fibrinogen; Hemostasis; Humans; Magnetic Resonance Imaging; Middle Aged; Peptide Hydrolases; Pipecolic Acids; Sulfonamides | 1999 |
Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
Topics: Adenosine Diphosphate; Animals; Antibodies, Antiphospholipid; Antibodies, Monoclonal; Antibody Specificity; Antiphospholipid Syndrome; Autoimmune Diseases; Biomarkers; Blood Coagulation Factors; Blood Platelets; Cattle; Cells, Cultured; Dose-Response Relationship, Immunologic; Endothelium, Vascular; Female; Fibrinogen; Humans; Immunoglobulin G; Intracranial Embolism; Lipopolysaccharides; Lupus Erythematosus, Systemic; Male; Middle Aged; Monocytes; Peptide Fragments; Platelet Activation; Recurrence; Thrombophilia; Thromboplastin | 2000 |
Risk of thromboembolic complications in patients with inflammatory bowel disease. Study of hemostasis measurements.
Topics: Adult; Antiphospholipid Syndrome; Antithrombin III; Autoantibodies; Blood Coagulation Factors; Blood Coagulation Tests; Cardiolipins; Colitis, Ulcerative; Crohn Disease; Disease Susceptibility; Female; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Male; Middle Aged; Plasminogen Inactivators; Risk Factors; Thromboembolism | 1991 |